01 August 2016 to 31 January 2021

Funder: Versus Arthritis (formerly Arthritis Research UK)

More information can be found, here.

Fatigue is pervasive, disabling and challenging to manage across all inflammatory rheumatic diseases. Therapies designed to improve physical activity and ‘talking’ treatments, which positively help patients change the way they think and behave, are both helpful in reducing the burden of the fatigue. However, few patients have access to these treatments in the NHS. We also don't understand how these treatments work or which patients are most likely to benefit. This information could help to improve future treatments making them more efficient.

Background and purpose of the study

With LIFT, we want to find out if a talking therapy (CBA) or personalised exercise programme (PEP) is better than usual care alone in helping you to reduce the impact of fatigue.

The LIFT study aims to recruit 375 adults aged 18 and over with inflammatory rheumatic diseases who experience significant fatigue from our six study centres in Aberdeen, Dundee, Edinburgh, Glasgow, Newcastle and Stoke-Midlands.  People who are suitable to take part in the study will be sent a letter by their direct care team. Recruitment started in August 2017 and will continue until September 2019.

You will receive either a talking therapy plus usual care, a personalised exercise programme plus usual care or usual care alone.

More information about LIFT is available, here.

Study Team
Study Sites

Photo Gallery

 

Contact Us

Mail:                LIFT Trial Office

 

    Epidemiology Group, University of Aberdeen
    Health Sciences Building, Foresterhill
    Aberdeen Scotland AB25 2ZD

 

Email:              lift@abdn.ac.uk

Phone:           01224 437228